ArticleBJU international2021

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance.

Anirudh Tomer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.